We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

47 hedge funds and large institutions have $27M invested in Cumberland Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less funds holding

Funds holding: 48 → 47 (-1)

10% less capital invested

Capital invested by funds: $30.1M → $27M (-$3.08M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

35% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 17

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
17
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$247K
2
Renaissance Technologies
Renaissance Technologies
New York
+$106K
3
SIM
Spark Investment Management
New York
+$37K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$31.3K
5
GCP
GSA Capital Partners
United Kingdom
+$14K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$384K
2
Norges Bank
Norges Bank
Norway
-$108K
3
TDC
Thompson Davis & Co
Virginia
-$85.5K
4
RA
Royce & Associates
New York
-$84K
5
BIT
BlackRock Institutional Trust
California
-$69.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
DAM
26
Delta Asset Management
Tennessee
$63K – – –
JAM
27
JW Asset Management
Florida
$58K – – –
Cambridge Investment Research Advisors
28
Cambridge Investment Research Advisors
Iowa
$53K – – –
RFC
29
Russell Frank Company
Washington
$27K – – –
BA
30
BlackRock Advisors
Delaware
$24K – – –
NFA
31
Nationwide Fund Advisors
Ohio
$20K – – –
OC
32
Oakworth Capital
Alabama
$16K – – –
PNC Financial Services Group
33
PNC Financial Services Group
Pennsylvania
$16K – – –
OSAM
34
O'Shaughnessy Asset Management
Connecticut
$11K -$2.13K -373 -16%
WIC
35
Woodmont Investment Counsel
Tennessee
$11K – – –
Walleye Trading
36
Walleye Trading
New York
$11K +$12K +2,100 New
BIM
37
BlackRock Investment Management
Delaware
$10K +$895 +157 +9%
Citigroup
38
Citigroup
New York
$6K -$1.71K -300 -20%
MA
39
MUFG Americas
New York
$6K +$6.84K +1,200 New
UMA
40
USA Mutuals Advisors
Texas
$4K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$4K +$4.12K +723 +4,820%
UBS Group
42
UBS Group
Switzerland
$3K -$7.46K -1,310 -70%
Deutsche Bank
43
Deutsche Bank
Germany
$3K -$490 -86 -10%
SEI Investments
44
SEI Investments
Pennsylvania
$1K -$684 -120 -49%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
Norges Bank
46
Norges Bank
Norway
– -$108K -18,734 Closed
RA
47
Royce & Associates
New York
– -$84K -14,600 Closed
Federated Hermes
48
Federated Hermes
Pennsylvania
– -$1K -171 Closed
1
2

CPIX Hedge Fund Activity: Q4 2015 in Review

47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2015, worth a combined $27M — down 10% from $30.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPIX and 2 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 11 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $247K. The largest seller was Ariel Investments, cutting an estimated $384K.

  • 47 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2015, down from 48 in Q3 2015.
  • Funds reported $27M of Cumberland Pharmaceuticals stock for Q4 2015, down 10% quarter-over-quarter.
  • 2 funds opened new Cumberland Pharmaceuticals positions in Q4 2015 and 3 closed out, a net change of -1 holder.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2015 was Bridgeway Capital Management, an estimated $247K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2015 was Ariel Investments, an estimated $384K sold.

Based on aggregated 13F filings for Q4 2015.